Leveraging nature’s nanocarriers: Translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications
Science Advances · 28.02.2025 · 11 (9)
DOI: 10.1126/sciadv.ads5249 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science Advances, erschienen am 28.02.2025. Verfasst von Yunxi Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada. Hauptthemen laut MEDLINE: Extracellular Vesicles, Biomimetic Materials, Nanoparticles, Biomimetics. Die Arbeit wurde bisher 110-mal zitiert (Crossref) und nennt 236 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Naturally occurring extracellular vesicles (EVs) and synthetic nanoparticles like liposomes have revolutionized precision diagnostics and medicine. EVs excel in biocompatibility and cell targeting, while liposomes offer enhanced drug loading capacity and scalability. The clinical translation of EVs is hindered by challenges including low yield and heterogeneity, whereas liposomes face rapid immune clearance and limited targeting efficiency. To bridge these gaps, biomimetic synthetic vesicles (SVs) have emerged as innovative platforms, combining the advantageous properties of EVs and liposomes. This review emphasizes critical aspects of EV biology, such as mechanisms of EV-cell interaction and source-dependent functionalities in targeting, immune modulation, and tissue regeneration, informing biomimetic SV engineering. We reviewed a broad array of biomimetic SVs, with a focus on lipid bilayered vesicles functionalized with proteins. These include cell-derived nanovesicles, protein-functionalized liposomes, and hybrid vesicles. By addressing current challenges and highlighting opportunities, this review aims to advance biomimetic SVs for transformative biomedical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
- Department of Pathology, McGill University, Montreal, QC, Canada.
- Department of Biomedical Engineering and Victor Philippe Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, QC, Canada.
- École de technologie supérieure ÉTS, Montreal, QC, Canada.
- Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada.
ORCID-Profile: Yunxi Chen, Thupten Tsering, Amélie Nadeau, David Juncker, Vahé Nerguizian, Julia V Burnier
Zitieren
APA
Chen, Y., Douanne, N., Wu, T., Kaur, I., Tsering, T., Erzingatzian, A., Nadeau, A., Juncker, D., Nerguizian, V., & Burnier, J. V. (2025). Leveraging nature’s nanocarriers: Translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications. Science Advances, 11(9). https://doi.org/10.1126/sciadv.ads5249
Vancouver
Chen Y, Douanne N, Wu T, Kaur I, Tsering T, Erzingatzian A, et al. Leveraging nature’s nanocarriers: Translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications. Science Advances. 2025;11(9). doi:10.1126/sciadv.ads5249
BibTeX
@article{Chen2025,
author = {Chen, Yunxi and Douanne, Noélie and Wu, Tad and Kaur, Ishman and Tsering, Thupten and Erzingatzian, Armen and Nadeau, Amélie and Juncker, David and Nerguizian, Vahé and Burnier, Julia V},
title = {Leveraging nature’s nanocarriers: Translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {9},
doi = {10.1126/sciadv.ads5249}
}
EUVIMED